Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.

By M. Teng, M. Wolf, E. Lowrie, N. Ofsthun, J. Lazarus, R. Thadhani. New England Journal of Medicine, 2003

975 citations recorded by the source corpus.

Subfields: Nephrology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/261a281cd795e188b39c4dd0817ea4bc3d9eb314

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Nephrology

1. Harold I. Feldman
2. J. Kusek

In Pathology and Forensic Medicine

1. M. Demay
2. M. F. Holick

Citations in the corpus

• Vitamin D and human health: lessons from vitamin D receptor null mice. (2008, result): “chronic renal failure patients, subsequently confirmed in smaller studies in other populations, revealed a survival benefit, especially cardiovascular, from treatment with a VDR agonist (613, 614).”
• Vitamin D signalling pathways in cancer: potential for anticancer therapeutics (2007, background): “4a ; 19-nor-1α,25-(OH) 2 D 2 , Zemplar), an analogue developed by Abbott, appears to be more effective than 1α,25(OH) 2 D 3 in the management of renal osteodystrophy and chronic renal diseas”
• Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. (2005, background): “14 death among patients on hemodialysis, suggesting that the protective effect of vitamin D is beyond calcium-phosphorus metabolism (32, 35).”
• Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients with Chronic Kidney Disease (2011, methodology): “Phosphate binders and active vitamin D therapy can modulate FGF-23 levels(15,16) and are associated with survival.(17,18) We adjusted for use of these medications and for use of vitamin D supplements and performed a sensitivity analysis that excluded participants who were receiving these agents at e”
• Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. (2005, background): “Guidelines have recently been promulgated [5, 6] based on the reported association of cardiovascular [13, 14] and skeletal consequences of altered mineral metabolism.”
• Activated injectable vitamin D and hemodialysis survival: a historical cohort study. (2005, background): “Finally, during the initial period included in this study, 1996 to 1999, the primary oral phosphate binders were calcium based; therefore, the contribution of alternative non–calciumbased oral phosphate binders was likely minimal (22).”